We further identified additional patients with mutations in ANXA11 and similar clinical presentations from a large neurodegenerative disease cohort, thereby establishing corticobasal syndrome as part of the phenotypic spectrum of ANXA11 mutations. This evidence concerns the gene ANXA11 and neurodegenerative disease.